These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19153090)

  • 41. [Comparison of agonists versus antagonists for i.v.f. stimulation: the French FIVNAT survey 2001-2002].
    Pouly JL; Bachelot A; de Mouzon J; Devaux A;
    Gynecol Obstet Fertil; 2004 Sep; 32(9):737-40. PubMed ID: 15380755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of protocols efficacy in poor responders: differences in oocytes/embryos competence with different protocols, a retrospective study.
    Manno M; Tomei F; Cervi M; Favretti C; Adamo V
    Fertil Steril; 2009 Apr; 91(4 Suppl):1431-3. PubMed ID: 18706554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate.
    Orvieto R; Patrizio P
    Reprod Biomed Online; 2013 Jan; 26(1):4-8. PubMed ID: 23186555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
    Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint.
    Polinder S; Heijnen EM; Macklon NS; Habbema JD; Fauser BJ; Eijkemans MJ
    Hum Reprod; 2008 Feb; 23(2):316-23. PubMed ID: 18033807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
    Fauser BC; Devroey P
    Fertil Steril; 2005 Jun; 83(6):1607-11. PubMed ID: 15950626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
    Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GnRH agonists vs antagonists.
    Tarlatzis BC; Kolibianakis EM
    Best Pract Res Clin Obstet Gynaecol; 2007 Feb; 21(1):57-65. PubMed ID: 17049460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
    Orvieto R; Rabinson J; Meltcer S; Gemer O; Anteby EY; Zohav E
    Fertil Steril; 2008 Mar; 89(3):736-7. PubMed ID: 17498708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr.
    Arslan M; Bocca S; Mirkin S; Barroso G; Stadtmauer L; Oehninger S
    Fertil Steril; 2005 Sep; 84(3):555-69. PubMed ID: 16169382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reassessing the feasibility of the zygote score for predicting embryo viability in IVF/ICSI using the GnRH antagonist protocol compared to the long protocol.
    Lin PY; Huang FJ; Kung FT; Lin YC; Chiang HJ; Lin YJ; Lan KC
    PLoS One; 2017; 12(2):e0171465. PubMed ID: 28152037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study.
    Ata B; Yakin K; Balaban B; Urman B
    Hum Reprod; 2008 Mar; 23(3):668-73. PubMed ID: 18192671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estradiol Pretreatment in an Ultrashort GnRH Combined with a GnRH Antagonist Protocol in A Cohort of Poor Responders Undergoing IVF/ICSI: A Case-control Study.
    Siristatidis C; Salamalekis G; Vogiatzi P; Vrantza T; Matsota P; Pergialiotis V; Papantoniou N
    In Vivo; 2016 11-12; 30(6):945-950. PubMed ID: 27815485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GnRH antagonists in assisted reproductive techniques: a review on the Italian experience.
    Marci R; Graziano A; Lo Monte G; Piva I; Soave I; Marra E; Lisi F; Moscarini M; Caserta D
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(7):853-73. PubMed ID: 23640431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.
    Nelson SM; Yates RW; Lyall H; Jamieson M; Traynor I; Gaudoin M; Mitchell P; Ambrose P; Fleming R
    Hum Reprod; 2009 Apr; 24(4):867-75. PubMed ID: 19136673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy.
    de Klerk C; Macklon NS; Heijnen EM; Eijkemans MJ; Fauser BC; Passchier J; Hunfeld JA
    Hum Reprod; 2007 Sep; 22(9):2554-8. PubMed ID: 17586832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Application of GnRH-antagonist to IVF-ET for patients with poor ovarian response].
    Wang B; Sun HX; Hu YL; Chen H; Zhang NY
    Zhonghua Nan Ke Xue; 2008 May; 14(5):423-6. PubMed ID: 18572861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mild ovarian stimulation for IVF.
    Verberg MF; Macklon NS; Nargund G; Frydman R; Devroey P; Broekmans FJ; Fauser BC
    Hum Reprod Update; 2009; 15(1):13-29. PubMed ID: 19091755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of severe ovarian hyperstimulation syndrome after inadvertent stimulation with a gonadotropin-releasing hormone agonist and human menopausal gonadotropin in a pre-existing early pregnancy.
    Zech NH; Netzbandt P; Zech H
    Fertil Steril; 2005 Dec; 84(6):1745. PubMed ID: 16359980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.